PSA glycoform profiling has been shown to provide better accuracy in detecting PCa compared with the conventional protein-level analysis of PSA in blood (15), which demonstrates the potential of using glycoprofiling to discover new and improve existing PCa biomarkers. This evidence concerns the gene KLK3 and posterior cortical atrophy.